Cause and treatment of multi-drug resistant pulmonary tuberculosis in patients with human immunodeficiency virus infection
- VernacularTitle:HIV感染合并耐多药肺结核的成因及疗效观察
- Author:
Xianmin ZHENG
;
Songmei LI
;
Baochun XING
- Publication Type:Journal Article
- Keywords:
human immunodeficiency virus, tuberculosis, pulmonary, combined drug therapy
- From:
Chinese Journal of Rehabilitation Theory and Practice
2005;11(9):739-741
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo explore the cause and treatment of multi-drug resistant pulmonary tuberculosis (MDR-TB) in patients with human immunodeficiency virus (HIV) infection. Methods24 cases with HIV and MDR-TB who were found in some AIDS-high areas in Henan were analyzed.ResultsAll cases were later-required drug-resistant ones. The main reasons were unreasonable plan for chemotherathy,improper management to the patients, side-effect of drugs,immunosuppression and low drug-tolerance. After anti-virus and 9～12 months long anti-tuberculosis chemotherathy,7 cases died and other 17 survival patients improved in clinical symptoms and signs, including no tubercle bacillus were found in sputum of 15 cases,the focal of infection were absorbed in 16 cases,the pulmonary cavity closure rate was 66.7%(4/6)and the count of CD4+ lymphocyte was higher than before.ConclusionThe patients with HIV and MDR-TB are difficult to cure and the mortality rate is high;the short-term effect of the anti-virus and multi-drug antituberculosis chemotherathy is better.
